Global Preclinical CRO Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	164 Pages	TechNavio	July, 2024	INF19384865

Best Price Guarantee
Price	from $2,500
Length	164 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19384865

Global Preclinical CRO Market 2024-2028

Global Preclinical Cro Market 2024-2028

The preclinical cro market is forecasted to grow by USD 2539.6 mn during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the preclinical cro market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical cro.

Technavio's preclinical cro market is segmented as below:

By End-user
Pharmaceutical and biopharmaceutical companies
Medical device companies
Academic institutes
By Service
Toxicology testing
Bioanalysis and DMPK studies
Compound management
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the preclinical cro market growth during the next few years. Also, rise in r and d budget for drug development and increasing demand for new drugs and medical treatments will lead to sizable demand in the market.

The report on the preclinical cro market covers the following areas:

Preclinical cro market sizing
Preclinical cro market forecast
Preclinical cro market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical cro market vendors that include Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON plc, Imavita S.A.S., IQVIA Holdings Inc., JSR Corp., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., Thermo Fisher Scientific Inc., Veeda Clinical Research Ltd., Vivotecnia, and WuXi AppTec Co. Ltd.. Also, the preclinical cro market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Service; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Preclinical CRO Market 2018 - 2022; Historic Market Size - Data Table on Global Preclinical CRO Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Service segment analysis 2018 - 2022; Historic Market Size - Service Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028; Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.4 Medical device companies - Market size and forecast 2023-2028; Chart on Medical device companies - Market size and forecast 2023-2028 ($ million); Data Table on Medical device companies - Market size and forecast 2023-2028 ($ million); Chart on Medical device companies - Year-over-year growth 2023-2028 (%); Data Table on Medical device companies - Year-over-year growth 2023-2028 (%); 6.5 Academic institutes - Market size and forecast 2023-2028; Chart on Academic institutes - Market size and forecast 2023-2028 ($ million); Data Table on Academic institutes - Market size and forecast 2023-2028 ($ million); Chart on Academic institutes - Year-over-year growth 2023-2028 (%); Data Table on Academic institutes - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Service: 7.1 Market segments; Chart on Service - Market share 2023-2028 (%); Data Table on Service - Market share 2023-2028 (%); 7.2 Comparison by Service; Chart on Comparison by Service; Data Table on Comparison by Service; 7.3 Toxicology testing - Market size and forecast 2023-2028; Chart on Toxicology testing - Market size and forecast 2023-2028 ($ million); Data Table on Toxicology testing - Market size and forecast 2023-2028 ($ million); Chart on Toxicology testing - Year-over-year growth 2023-2028 (%); Data Table on Toxicology testing - Year-over-year growth 2023-2028 (%); 7.4 Bioanalysis and DMPK studies - Market size and forecast 2023-2028; Chart on Bioanalysis and DMPK studies - Market size and forecast 2023-2028 ($ million); Data Table on Bioanalysis and DMPK studies - Market size and forecast 2023-2028 ($ million); Chart on Bioanalysis and DMPK studies - Year-over-year growth 2023-2028 (%); Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2023-2028 (%); 7.5 Compound management - Market size and forecast 2023-2028; Chart on Compound management - Market size and forecast 2023-2028 ($ million); Data Table on Compound management - Market size and forecast 2023-2028 ($ million); Chart on Compound management - Year-over-year growth 2023-2028 (%); Data Table on Compound management - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Service; Market opportunity by Service ($ million); Data Table on Market opportunity by Service ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Altasciences; Altasciences - Overview; Altasciences - Product / Service; Altasciences - Key offerings; 12.4 AmplifyBio; AmplifyBio - Overview; AmplifyBio - Product / Service; AmplifyBio - Key offerings; 12.5 Charles River Laboratories International Inc.; Charles River Laboratories International Inc. - Overview; Charles River Laboratories International Inc. - Business segments; Charles River Laboratories International Inc. - Key offerings; Charles River Laboratories International Inc. - Segment focus; 12.6 Eurofins Scientific SE; Eurofins Scientific SE - Overview; Eurofins Scientific SE - Business segments; Eurofins Scientific SE - Key news; Eurofins Scientific SE - Key offerings; Eurofins Scientific SE - Segment focus; 12.7 ICON plc; ICON plc - Overview; ICON plc - Product / Service; ICON plc - Key offerings; 12.8 Imavita S.A.S.; Imavita S.A.S. - Overview; Imavita S.A.S. - Product / Service; Imavita S.A.S. - Key offerings; 12.9 IQVIA Holdings Inc.; IQVIA Holdings Inc. - Overview; IQVIA Holdings Inc. - Business segments; IQVIA Holdings Inc. - Key news; IQVIA Holdings Inc. - Key offerings; IQVIA Holdings Inc. - Segment focus; 12.10 JSR Corp.; JSR Corp. - Overview; JSR Corp. - Business segments; JSR Corp. - Key offerings; JSR Corp. - Segment focus; 12.11 Kunming Biomed International Ltd.; Kunming Biomed International Ltd. - Overview; Kunming Biomed International Ltd. - Product / Service; Kunming Biomed International Ltd. - Key offerings; 12.12 Laboratory Corp. of America Holdings; Laboratory Corp. of America Holdings - Overview; Laboratory Corp. of America Holdings - Business segments; Laboratory Corp. of America Holdings - Key news; Laboratory Corp. of America Holdings - Key offerings; Laboratory Corp. of America Holdings - Segment focus; 12.13 Medpace Holdings Inc.; Medpace Holdings Inc. - Overview; Medpace Holdings Inc. - Product / Service; Medpace Holdings Inc. - Key offerings; 12.14 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; 12.15 Veeda Clinical Research Ltd.; Veeda Clinical Research Ltd. - Overview; Veeda Clinical Research Ltd. - Product / Service; Veeda Clinical Research Ltd. - Key offerings; 12.16 Vivotecnia; Vivotecnia - Overview; Vivotecnia - Product / Service; Vivotecnia - Key offerings; 12.17 WuXi AppTec Co. Ltd.; WuXi AppTec Co. Ltd. - Overview; WuXi AppTec Co. Ltd. - Business segments; WuXi AppTec Co. Ltd. - Key offerings; WuXi AppTec Co. Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Service; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Preclinical CRO Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Service Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Medical device companies - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Medical device companies - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Academic institutes - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Academic institutes - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ million); Exhibits49: Data Table on Market opportunity by End-user ($ million); Exhibits50: Chart on Service - Market share 2023-2028 (%); Exhibits51: Data Table on Service - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Service; Exhibits53: Data Table on Comparison by Service; Exhibits54: Chart on Toxicology testing - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Toxicology testing - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Toxicology testing - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Toxicology testing - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Bioanalysis and DMPK studies - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Bioanalysis and DMPK studies - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Bioanalysis and DMPK studies - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Compound management - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Compound management - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Compound management - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Compound management - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Service ($ million); Exhibits71: Data Table on Market opportunity by Service ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Altasciences - Overview; Exhibits122: Altasciences - Product / Service; Exhibits123: Altasciences - Key offerings; Exhibits124: AmplifyBio - Overview; Exhibits125: AmplifyBio - Product / Service; Exhibits126: AmplifyBio - Key offerings; Exhibits127: Charles River Laboratories International Inc. - Overview; Exhibits128: Charles River Laboratories International Inc. - Business segments; Exhibits129: Charles River Laboratories International Inc. - Key offerings; Exhibits130: Charles River Laboratories International Inc. - Segment focus; Exhibits131: Eurofins Scientific SE - Overview; Exhibits132: Eurofins Scientific SE - Business segments; Exhibits133: Eurofins Scientific SE - Key news; Exhibits134: Eurofins Scientific SE - Key offerings; Exhibits135: Eurofins Scientific SE - Segment focus; Exhibits136: ICON plc - Overview; Exhibits137: ICON plc - Product / Service; Exhibits138: ICON plc - Key offerings; Exhibits139: Imavita S.A.S. - Overview; Exhibits140: Imavita S.A.S. - Product / Service; Exhibits141: Imavita S.A.S. - Key offerings; Exhibits142: IQVIA Holdings Inc. - Overview; Exhibits143: IQVIA Holdings Inc. - Business segments; Exhibits144: IQVIA Holdings Inc. - Key news; Exhibits145: IQVIA Holdings Inc. - Key offerings; Exhibits146: IQVIA Holdings Inc. - Segment focus; Exhibits147: JSR Corp. - Overview; Exhibits148: JSR Corp. - Business segments; Exhibits149: JSR Corp. - Key offerings; Exhibits150: JSR Corp. - Segment focus; Exhibits151: Kunming Biomed International Ltd. - Overview; Exhibits152: Kunming Biomed International Ltd. - Product / Service; Exhibits153: Kunming Biomed International Ltd. - Key offerings; Exhibits154: Laboratory Corp. of America Holdings - Overview; Exhibits155: Laboratory Corp. of America Holdings - Business segments; Exhibits156: Laboratory Corp. of America Holdings - Key news; Exhibits157: Laboratory Corp. of America Holdings - Key offerings; Exhibits158: Laboratory Corp. of America Holdings - Segment focus; Exhibits159: Medpace Holdings Inc. - Overview; Exhibits160: Medpace Holdings Inc. - Product / Service; Exhibits161: Medpace Holdings Inc. - Key offerings; Exhibits162: Thermo Fisher Scientific Inc. - Overview; Exhibits163: Thermo Fisher Scientific Inc. - Business segments; Exhibits164: Thermo Fisher Scientific Inc. - Key news; Exhibits165: Thermo Fisher Scientific Inc. - Key offerings; Exhibits166: Thermo Fisher Scientific Inc. - Segment focus; Exhibits167: Veeda Clinical Research Ltd. - Overview; Exhibits168: Veeda Clinical Research Ltd. - Product / Service; Exhibits169: Veeda Clinical Research Ltd. - Key offerings; Exhibits170: Vivotecnia - Overview; Exhibits171: Vivotecnia - Product / Service; Exhibits172: Vivotecnia - Key offerings; Exhibits173: WuXi AppTec Co. Ltd. - Overview; Exhibits174: WuXi AppTec Co. Ltd. - Business segments; Exhibits175: WuXi AppTec Co. Ltd. - Key offerings; Exhibits176: WuXi AppTec Co. Ltd. - Segment focus; Exhibits177: Inclusions checklist; Exhibits178: Exclusions checklist; Exhibits179: Currency conversion rates for US$; Exhibits180: Research methodology; Exhibits181: Information sources; Exhibits182: Data validation; Exhibits183: Validation techniques employed for market sizing; Exhibits184: Data synthesis; Exhibits185: 360 degree market analysis; Exhibits186: List of abbreviations